

AI Workflows for Biopharma with Alex Telford
Mar 23, 2025
In this engaging discussion, Alex Telford, Co-founder and CEO of Convoke, dives into the pivotal role of forecasting in biopharma development, emphasizing its strategic importance in preclinical stages. He also highlights the transformative potential of technology, such as natural language processing, to reshape data analysis and improve collaboration in the industry. Alex shares insights on bridging the gap between biotech and tech cultures, the necessity of a writing culture in growing companies, and the value of diverse reading habits for industry professionals.
AI Snips
Chapters
Transcript
Episode notes
Commercial Analysis Is Too Manual
- Commercial analyses require heavy manual work and become outdated fast.
- Alex Telford says this delays commercial input and harms development decisions.
Consulting Exposed Repeated Data Waste
- Consulting exposed repeated manual reading and reconciliation across trials, papers, and filings.
- Alex Telford observed those analyses just sit on a digital shelf and get redone by new teams.
LLMs Finally Crossed The Utility Threshold
- Large language models now automate many NLP tasks previously infeasible.
- Alex Telford points to GPT-2/3 and lower API costs as the trigger.